Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	46.66B
Revenue (ttm)	18.60B
Net Income (ttm)	1.45B
Shares Out	1.37B
EPS (ttm)	1.06
PE Ratio	32.16
Forward PE	32.25
Dividend	1.00 (2.94%)
Ex-Dividend Date	Jun 30, 2025

Volume	7,764,067
Average Volume	9,631,326
Open	34.21
Previous Close	34.21
Day's Range	33.98 - 34.23
52-Week Range	33.30 - 46.27
Beta	0.15
RSI	30.76
Earnings Date	Oct 29, 2025

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. The company offers various product dosage forms, such as pills, dripping pills, powders, capsules, oral liquids, and tonics, as well as alcoholic preparations. It also engages in medicine plantation; aquaculture; investment management; and other related services. The company exports its products. Its products are used for cardiovascular, gynecology, heat clearing class, respiratory system, nourishing...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.